Clinical Trial Update: Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa [Phase 3]

View source ↗

Summary

Phase 3 trial of adalimumab for hidradenitis suppurativa completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Hidradenitis Suppurativa (HS) | Phase 3 | Status: COMPLETED | Results posted: 2015-10-28